ARM’s Tim Hunt says the FDA ‘has stabilized’ and points to seven more blockbusters at Meeting on the Mesa
Tim Hunt told Cell & Gene Meeting on the Mesa that Wall Street data point to seven more cell and gene therapy blockbusters, and said ARM will soon announce changes to its membership dues.